Vaginal Mesh Lawsuits: Two Juries Awarded Large Verdicts For Vaginal Mesh That Contracted and Eroded Causing Health Problems by Texas Vaginal Mesh Lawyer Jason S. Coomer

Vaginal Mesh Lawsuits: Two Juries Have Awarded Large Verdicts To Women That Had Vaginal Mesh Implanted In Them Contract and Erode Causing Serious Health Problems by Texas Vaginal Mesh Lawyer Jason S. Coomer

Thousands of women, who have had vaginal mesh implanted in them during surgery, are at an increased risk of suffering significant health problems from recalled vaginal mesh.  These health problems can be caused by mesh erosion, mesh deterioration, and mesh contraction and can include recurrence of prolapse and/or incontinence; bowel perforation; bladder perforation; blood vessel perforation; neurological problems; erosion of the mesh through vagina infection; urinary problems; and vaginal epithelium.  These health issues can often require multiple surgeries to repair or cause permanent health problems. 

If you or a loved one has suffered significant health problems from a failed vaginal mesh, it is important to seek immediate medical attention.  For more information on contracted vaginal mesh lawsuits or eroded vaginal mesh lawsuits, please feel free to contact Texas Failed Vaginal Mesh Surgery Lawyer, Jason Coomer, via e-mail message or go to the following webpage: Vaginal Mesh Lawsuit Information.

N.J. jury awards woman $7.76 mln punitive damages for vaginal mesh | Reuters

"A New Jersey jury on Thursday ordered Johnson & Johnson to pay $7.76 million in punitive damages to a South Dakota nurse who claimed harm from the company's now-recalled Prolift vaginal mesh."

Johnson & Johnson Told to Pay $3.35 Million in Vaginal Mesh Case - NYTimes.com

On February 25, 2013, a jury awarded $3.35 million to a woman who suffered a failed vaginal mesh surgery.  The failed vaginal mesh implant caused the woman to suffer erosion, scar tissue, inflammation and neurologic compromise.  The woman had to seek significant medical treatment including having to endure 18 operations to repair the damage caused by the failed vaginal mesh.  

These cases are some the first vaginal mesh lawsuits to reach a jury and many more failed vaginal mesh lawsuits are currently pending.

Transvaginal Mesh Surgery Lawsuits: Jury Awards $3.35 Million in Transvaginal Mesh Lawsuit by Transvaginal Mesh Lawyer Jason S. Coomer

Transvaginal Mesh Surgery Lawsuits: A Jury Awarded $3.35 Million to a Woman Who Suffered Transvaginal Mesh Failure and Had to Have 18 Operations to Repair the Damages She Suffered from the Transvaginal Mesh Failure by Transvaginal Mesh Lawyer Jason S. Coomer

On February 25, 2013, a jury awarded $3.35 million to a woman who suffered a failed transvaginal mesh surgery.  The failed transvaginal mesh surgery caused the woman to suffer erosion, scar tissue, inflammation and neurologic compromise.  The woman had to seek significant medical treatment including having to endure 18 operations to repair the damage caused by the failed transvaginal mesh.  This case in one of the first transvaginal mesh lawsuits to reach a jury and many more failed transvaginal mesh lawsuits are currently pending.

If you or a loved one has suffered from a failed transvaginal mesh surgery, it is important to seek immediate medical attention.  For more information on failed tranvaginal mesh surgery lawsuits, failed pelvic organ prolapse (POP) surgery lawsuits, or failed stress urinary incontinence (SUI) surgery lawsuits, please feel free to contact Failed Transvaginal Mesh Surgery Lawyer, Jason Coomer, via e-mail message or go to the following webpage: Transvaginal Mesh Surgery Lawsuit Information

 Transvaginal Mesh FDA Safety Communications and Actions

On July 13, 2011, the United States Food and Drug Administration released the below FDA Safety Communication update regarding Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse.  This FDA Safety Communication and other FDA Actions were intended to provide adequate safety warnings to women and their health care providers regarding the potential health risk of transvaginal mesh.  Women considering transvaginal mesh surgery and their health care providers should be aware of these potential health risks.

Audience:

Health care providers who implant surgical mesh to repair pelvic organ prolapse and/or stress urinary incontinence.

Health care providers involved in the care of patients with surgical mesh implanted to repair pelvic organ prolapse and/or stress urinary incontinence.

Patients who are considering or have received a surgical mesh implant to repair pelvic organ prolapse and/or stress urinary incontinence

Medical Specialties: gynecology, urogynecology, urology, general surgery, internal medicine, family practice, emergency medicine

Device:

Surgical mesh is a medical device that is generally used to repair weakened or damaged tissue. It is made from porous absorbable or non-absorbable synthetic material or absorbable biologic material. In urogynecologic procedures, surgical mesh is permanently implanted to reinforce the weakened vaginal wall to repair pelvic organ prolapse or to support the urethra to treat urinary incontinence.

Background:

Pelvic Organ Prolapse
Pelvic organ prolapse (POP) occurs when the tissues that hold the pelvic organs in place become weak or stretched. Thirty to fifty percent of women may experience POP in their lifetime with 2 percent developing symptoms. When POP happens, the organs bulge (prolapse) into the vagina and sometimes prolapse past the vaginal opening. More than one pelvic organ can prolapse at the same time. Organs that can be involved in POP include the bladder, the uterus, the rectum, the top of the vagina (vaginal apex) after a hysterectomy, and the bowel.

Stress Urinary Incontinence:

Stress urinary incontinence (SUI) is a leakage of urine during moments of physical activity, such as coughing, sneezing, laughing, or exercise.

Failed Transvaginal Mesh Surgery and Failed Transvaginal Mesh Surgery Lawsuits

There are still many women who have failed transvaginal mesh surgery and have suffered significant health problems from the failed surgery including recurrence of prolapse and/or incontinence, erosion of the mesh through the vagina infection, pain, urinary problems, vaginal epithelium, bowel perforation, bladder perforation, and blood vessel perforation.  If you or a loved one has suffered from a failed transvaginal mesh surgery, it is important to seek immediate medical attention.  For information on a failed transvaginal mesh surgery lawsuits, please feel free to contact Failed Transvaginal Surgery Lawyer, Jason Coomer, via e-mail message or go to the following web page on Failed Transvaginal Surgery Lawsuit Information

Pancreatic Cancer Causes: Several Diabetic Drugs Have Been Shown to Cause An Increased Risk of Pancreatic Cancer by Pancreatic Cancer Lawyer Jason S. Coomer

 Pancreatic Cancer Causes: Several Different Types of Diabetes Drugs Have Been Shown To Cause An Increased Risk of Pancreatic Cancer by Pancreatic Cancer Lawyer Jason S. Coomer

Recent scientific studies have shown that several diabetes drugs may cause an increased risk of pancreatic cancer.  People that are taking Onglyza, Tradjenta, Bydureon, Oseni, Byetta, Victoza, Januvia, or Janumet should be aware of the potential dangers of these drugs and should discuss the potential dangers of these drugs with their physician.  

If you have lost a loved one from Pancreatic Cancer who was taking a diabetes drug or you have been taking a diabetes drug and have been diagnosed with Pancreatic Cancer, please report the adverse action to the prescribing medical doctor and FDA as soon as possible.  Attorneys are in the process of filing and reviewing lawsuits where a person has developed pancreatic cancer after taking Onglyza, Tradjenta, Bydureon, Oseni, Byetta, Victoza, Januvia, and/or Janumet. For more information on this topic, please feel free to contact Pancreatic Cancer Lawyer, Jason S. Coomer or go to the following webpage: Pancreatic Cancer Lawsuit Information.

Pancreatic Cancer Detection: Understanding and Identifying Symptoms of Pancreatic Cancer Can Be Important In Early Detection and Treatment of Pancreatic Cancer Resulting in Higher Pancreatic Cancer Survival Rates

Symptoms of pancreatic cancer can include: dark urine and clay-colored stools, fatigue and weakness, jaundice (a yellow color in the skin, mucus membranes, or eyes), loss of appetite and weight loss, nausea and vomiting, pain or discomfort in the upper part of the belly or abdomen, back pain, blood clots, diarrhea, and indigestion.

Pancreatic cancer is often not detected early on and is often advanced when it is first found.  As such, ninety-five percent of the people diagnosed with this cancer will not be alive 5 years later.  Some patients have pancreatic cancer that can be surgically removed are cured. However, in more than 80% of patients the tumor has already spread and cannot be completely removed at the time of diagnosis.  In the few cases where pancreatic tumors can be removed by surgery. The standard surgical procedure to remove pancreatic tumors is called a Whipple procedure (pancreatoduodenectomy or pancreaticoduodenectomy). This surgery should be done by an experienced surgeon and at a medical center that performs the procedure often. Some studies suggest that the Whipple procedure is best performed at hospitals that do more than five of these surgeries per year.

When the tumor has not spread out of the pancreas, but cannot be removed, radiation therapy and chemotherapy together may be recommended. When the tumor has spread (metastasized) to other organs such as the liver, chemotherapy alone is usually used. The standard chemotherapy drug is gemcitabine, but other drugs may be used. Gemcitabine can help about 25% of patients.

Patients whose tumor cannot be totally removed, but who have a blockage of the tubes that transport bile (biliary obstruction) must have that blockage relieved. There are two approaches including surgery and placement of a tiny metal tube (biliary stent) during ERCP.

Managing pain and other symptoms is an important part of treating advanced pancreatic cancer. Palliative care tams and hospice can help with pain and symptom management, and provide psychological support for patients and their families during the illness.

The Diabetes Drug Market is Over $40 Billion Each Year and Growing Rapidly Encouraging Drug Companies To Push Dangerous Diabetes Drugs For Profits

More than 300 million people worldwide suffer from diabetes, including about 30 million Americans.  In 2010, the global prevalence of diabetes was estimated to have reached 285 million and predicted to reach 438 million by 2030. The corresponding figures for North America were 37.4 million in 2010 and 53.2 million by 2030 and in Europe 55.2 million in 2010 and 66.2 million in 2030.  The global market for products in the management of diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018.